Actualités et vidéos - LAKE SHORE BANCORP INC.

PUPS' Seventh Chicago Location Offers Urban Pet Parents Convenient, Health Club Quality Pet Care CHICAGO, IL / ACCESS Newswire / February 11, 2025 / WagWay Group, a platform company of Access Holdings, today announced the opening of its seventh PUPS Pet Club location in Chicago. Pet parents in the bustling Lakeshore East neighborhood will now have easy access to PUPS' innovative whole health approach to modern canine wellness offering dog daycare, grooming, overnight boarding and training...

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance PR Newswire BEIJING, Dec. 19, 2024 Achieved total revenue of RMB 371.9 million , reflecting a growth of 36.2% YoY Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY Gross margin increased to 82.6% from 80.9% in the same period of FY2024 Total operating expenses decreased to RMB 276.4 million, down 31.6% YoY Recorded net income of RMB 20.6 million, and...

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire GAITHERSBURG, Md., Oct. 29, 2024 GAITHERSBURG, Md. , Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a written...

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire GAITHERSBURG, Md., Oct. 29, 2024 GAITHERSBURG, Md. , Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has received a written...

LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine PR Newswire GAITHERSBURG, Md., Oct. 25, 2024 GAITHERSBURG, Md. , Oct. 25, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today...

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance PR Newswire GAITHERSBURG, Md., Oct. 8, 2024 GAITHERSBURG, Md. , Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today...

LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance PR Newswire GAITHERSBURG, Md., Oct. 8, 2024 GAITHERSBURG, Md. , Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today...

LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation PR Newswire GAITHERSBURG, Md., Sept. 27, 2024 GAITHERSBURG, Md. , Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the results of...

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 PR Newswire GAITHERSBURG, Md., Sept. 10, 2024 GAITHERSBURG, Md. , Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it...

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 PR Newswire GAITHERSBURG, Md., Sept. 10, 2024 GAITHERSBURG, Md. , Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it...

LakeShore Biopharma Announces Leadership Transitions PR Newswire GAITHERSBURG, Md., Sept. 4, 2024 GAITHERSBURG, Md. , Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the board of directors of the Company (the "Board")...

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., Aug. 15, 2024 Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md. , Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., Aug. 15, 2024 Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md. , Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition PR Newswire GAITHERSBURG, Md., July 5, 2024 GAITHERSBURG, Md. , July 5, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today...

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition PR Newswire GAITHERSBURG, Md., July 5, 2024 GAITHERSBURG, Md. , July 5, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today...

YS Biopharma Announces Name Change to LakeShore Biopharma PR Newswire GAITHERSBURG, Md., May 24, 2024 GAITHERSBURG, Md. , May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced it is changing its legal name from "YS Biopharma Co., Ltd." to...

Hydro One announces the Chatham to Lakeshore Transmission Line is on track to energize southwest Ontario a year ahead of schedule PR Newswire CHATHAM-KENT, ON, Nov. 3, 2023 By completing the line early, the Windsor - Essex region will benefit from increased reliability and resiliency, supporting the region's clean energy future CHATHAM -KENT, ON , Nov. 3, 2023 /PRNewswire/ - Today, Hydro One Networks Inc. (Hydro One) announced that the Chatham to Lakeshore Transmission Line is on track to be...

Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus PR Newswire SAN FRANCISCO, Dec. 2, 2022 SAN FRANCISCO , Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all proposals related to the previously announced business combination (the "Business Combination") with ProSomnus Holdings, Inc. ("ProSomnus") at a special meeting of shareholders held on December 2, 2022 ....

Nature's Miracle, a Leader in the Controlled Environment Agriculture Industry, Signed an MOU with Canadian Greenhouse Developer-Vermillion Growers, Inc. to Build a 60-Acre Greenhouse with Total EPC Value of US$114 Million PR Newswire UPLAND, Calif., Sept. 13, 2022 UPLAND, Calif. , Sept. 13, 2022 /PRNewswire/ -- Nature's Miracle Inc. ("Nature's Miracle"), announced that it has entered into a Memorandum of Understanding ("MOU") with Vermillion Growers, Inc. to develop a 60-acre vegetable...

Nature's Miracle, a Leader in the Controlled Environment Agriculture Industry, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition II Corp. PR Newswire UPLAND, Calif., Sept. 10, 2022 Nature's Miracle is a fast-growing agriculture technology company providing services to growers in Controlled Environment Agriculture ("CEA") settings in North America ; Nature's Miracle provides hardware as well as software to design, build and operate various indoor growing settings...